EDMOND DE ROTHSCHILD HOLDING S.A. - GW PHARMACEUTICALS PLC ownership

GW PHARMACEUTICALS PLC's ticker is GWPH and the CUSIP is 36197T103. A total of 2 filers reported holding GW PHARMACEUTICALS PLC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
EDMOND DE ROTHSCHILD HOLDING S.A. ownership history of GW PHARMACEUTICALS PLC
ValueSharesWeighting
Q1 2021$130,000
+88.4%
6000.0%0.00%
+100.0%
Q4 2020$69,000
+19.0%
6000.0%0.00%0.0%
Q3 2020$58,000
-21.6%
6000.0%0.00%
-33.3%
Q2 2020$74,000
+39.6%
6000.0%0.00%0.0%
Q1 2020$53,000
-15.9%
6000.0%0.00%
+50.0%
Q4 2019$63,000
-8.7%
6000.0%0.00%
-33.3%
Q3 2019$69,000
-33.0%
6000.0%0.00%
-25.0%
Q2 2019$103,000
+2.0%
6000.0%0.00%
+33.3%
Q1 2019$101,000
+48.5%
600
-14.3%
0.00%
+50.0%
Q4 2018$68,000
-34.6%
700
+16.7%
0.00%
-33.3%
Q3 2018$104,000
+23.8%
6000.0%0.00%
+50.0%
Q2 2018$84,000
+23.5%
6000.0%0.00%0.0%
Q1 2018$68,000
-13.9%
6000.0%0.00%0.0%
Q4 2017$79,000
+29.5%
6000.0%0.00%0.0%
Q3 2017$61,000
+1.7%
6000.0%0.00%0.0%
Q2 2017$60,000
-17.8%
6000.0%0.00%0.0%
Q1 2017$73,000
+9.0%
6000.0%0.00%0.0%
Q4 2016$67,000
-16.2%
6000.0%0.00%0.0%
Q3 2016$80,000
+45.5%
6000.0%0.00%0.0%
Q2 2016$55,000
+27.9%
6000.0%0.00%
+100.0%
Q1 2016$43,000
-21.8%
6000.0%0.00%0.0%
Q3 2015$55,000
-25.7%
6000.0%0.00%
-50.0%
Q2 2015$74,0006000.00%
Other shareholders
GW PHARMACEUTICALS PLC shareholders Q2 2021
NameSharesValueWeighting ↓
GREAT POINT PARTNERS LLC 390,000$45,010,0007.31%
Copernicus Capital Management, LLC 2,788$322,0005.02%
Integral Health Asset Management, LLC 72,500$8,367,0002.49%
Parkman Healthcare Partners LLC 81,573$9,414,0002.41%
AdvisorShares Investments LLC 66,317$7,654,0001.78%
Tri Locum Partners LP 40,159$4,635,0001.68%
ETF MANAGERS GROUP, LLC 621,361$71,711,0001.57%
Redmile Group, LLC 815,681$94,138,0001.14%
Redwood Investments, LLC 108,999$12,580,0001.07%
ROOSEVELT INVESTMENT GROUP LLC 127,885$14,759,0001.05%
View complete list of GW PHARMACEUTICALS PLC shareholders